Joel Greenblatt's position in Ionis Pharmaceuticals is currently worth $292 Thousand. That's 0.01% of their equity portfolio (1111th largest holding). The first Ionis Pharmaceuticals trade was made in Q4 2016. Since then Joel Greenblatt bought shares ten more times and sold shares on ten occasions. The stake costed the investor $264 Thousand, netting the investor a gain of 11% so far.